Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 8, 20142,000 sq. ft. interactive laboratory environment expansion funded by BD Diagnostics
BALTIMORE, MD, May 8, 2014 – The Maryland Science Center’s newly expanded and re-imagined space, SciLab, is now open, providing a unique, popular and hands-on laboratory science simulation for...
-
May 7, 2014Move Increases Size of Board to 10 Members
SAN DIEGO, CA, May 7, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced that Supratim Bose has been elected as the 10th member of its board...
-
May 7, 2014
BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the availability of the FDA-cleared BD MAX(TM) Enteric...
-
May 5, 2014Third quarter revenue increased 7 percent to $968 million, driven by continued growth in the company's Procedural Solutions segment
SAN DIEGO, May 5, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its third quarter of fiscal 2014, ended...
-
May 2, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Deutsche Bank 39(th) Annual Health Care Conference on...
-
May 1, 2014- Announces revenues of $2.072 billion, an increase of 3.6 percent, or 5.1 percent on a foreign currency-neutral basis.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.072 billion for the second fiscal quarter ended March 31, 2014,...
-
Apr 24, 2014Also Introduces the pink Achieve® Breast Biopsy Device
SAN DIEGO, CA, March 24, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, launched its new AVAflex ® Vertebral Balloon System today at the 39th annual Scientific...
-
Apr 24, 2014Easy-to-use CD4 analysis platform tailored to meet the needs of resource-limited settings
BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSPresto(TM) Near Patient CD4...
-
Apr 22, 2014CareFusion Technology Receives Top Marks for Quality, Ease of Use and Reliability
SAN DIEGO, April 22, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced that nurses have ranked the Pyxis MedStation® system as the #1...
-
Apr 9, 2014BD MAX™ GC rt PCR Assay Receives CE Mark
BALTIMORE, MD, April 09, 2014 – BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the CE mark and launch of the BD...